<DOC>
	<DOCNO>NCT02638077</DOCNO>
	<brief_summary>- To find gap real-world clinical practice guideline recommendation initial management DTC patient - To observe characteristic patient achieve achieve TSH target value one year follow-up - To assess response initial therapy patient undergo total near-total thyroidectomy RAI remnant ablation one year follow-up ( accord modify dynamic risk stratification system ) - To observe recurrence status one year follow-up</brief_summary>
	<brief_title>Initial Management Patients With Differentiated Thyroid Cancer Real World China</brief_title>
	<detailed_description>Multi-center , prospective , registry study 2000 DTC patient undergo first-time thyroidectomy identify intermediate high risk recurrence recruit . Doctors treat patient base disease condition . Investigators record data relate study endpoint . Primary endpoint ( ) : 1 . Proportion patient underwent total/near-total thyroidectomy 2 . Proportion patient treat 131I undergoing total/near-total thyroidectomy 3 . Proportion patient achieve serum TSH target value 4 . Proportion patient achieve serum TSH target value although treated TSH suppression therapy Secondary endpoint ( ) : 1 . Time achieve serum TSH target value 2 . Dosage L-T4 patient achieve achieve serum TSH target value 3 . Dosage L-T4 per kilogram body weight patient achieve achieve serum TSH target value 4 . Proportion excellent response/Acceptable response/Biochemical incomplete response/Structural incomplete response initial management patient undergo total near-total thyroidectomy RAI remnant ablation one year follow-up 5 . Recurrence rate one year follow-up 6. AEs relate L-T4 ( thyroid tablet ) treatment</detailed_description>
	<mesh_term>Thyroid Diseases</mesh_term>
	<mesh_term>Thyroid Neoplasms</mesh_term>
	<criteria>1 . Patients diagnose DTC ( diagnosis base preoperative examination postoperative pathology report ) 2 . Patients undergo firsttime thyroidectomy 3 . Patients identified intermediaterisk highrisk recurrence thyroidectomy ( accord recurrence risk stratification Chinese management guideline patient thyroid nodule differentiate thyroid cancer publish 2012 ) 4 . Patients Chinese nationality 5 . Patients sign informed consent form 1 . History thyroid surgery 2 . Other malignant tumor 3 . Severe organ damage heart failure New York Heart Association class IIIIV , liverfailure , respiratory failure , renal failure , etc . 4 . Medical psychological condition would permit patient complete study sign inform consent 5 . Legal incapacity limit legal capacity 6 . Unwilling follow</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Differentiated Thyroid Cancer</keyword>
	<keyword>initial management</keyword>
</DOC>